PRESS RELEASE published on 07/13/2026 at 21:20, 2 months 3 days ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook Evotec SE announces preliminary second quarter and first half 2026 results, updates full-year 2026 outlook. Key factors include revenue shift to 2027, strategic partnership delays, and base business momentum Evotec SE Preliminary Results Full-year Outlook Revenue Shift Base Business Momentum
PRESS RELEASE published on 07/13/2026 at 21:17, 2 months 3 days ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook Evotec SE announces preliminary second quarter and first half 2026 results and updates full-year 2026 outlook, reflecting adjusted financial figures and revised guidance Evotec SE Preliminary Results Financial Figures Full-year Outlook Revised Guidance
BRIEF published on 06/30/2026 at 07:35, 2 months 16 days ago Evotec AG Introduces J.TRAIN for Efficient Biologics Manufacturing Productivity Cost Efficiency Biologics Continuous Manufacturing J.TRAIN
PRESS RELEASE published on 06/30/2026 at 07:30, 2 months 16 days ago Just – Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics Evotec SE introduces J.TRAIN, a turnkey continuous manufacturing solution for biologics, enabling faster deployment and increased productivity. The model combines modular infrastructure, equipment, and technology for efficient capacity increase Technology Evotec SE Biologics Continuous Manufacturing J.TRAIN
BRIEF published on 06/11/2026 at 15:35, 3 months 5 days ago Evotec Announces Outcomes of 2026 Annual General Meeting Annual General Meeting Drug Discovery Evotec SE Supervisory Board Shareholder Voting
PRESS RELEASE published on 06/11/2026 at 15:30, 3 months 5 days ago Evotec Reports Results of the Annual General Meeting 2026 Evotec SE reports the results of its 2026 Annual General Meeting, including newly elected Supervisory Board members and voting outcomes. For more details, visit their website Annual General Meeting Shareholders Voting Results Evotec SE Supervisory Board
BRIEF published on 06/02/2026 at 07:35, 3 months 14 days ago Evotec Appoints Rui Wang as Head of Global In Silico and AI Drug Discovery Evotec SE AI In Pharma Rui Wang In Silico Innovation
PRESS RELEASE published on 06/02/2026 at 07:30, 3 months 14 days ago Evotec Appoints Rui Wang as Head of Global In Silico and AI Evotec SE appoints Rui Wang as Head of Global In Silico and AI, bringing over 20 years of experience in enterprise data and AI strategies for pharmaceutical and biotechnology operations Biotechnology AI Pharmaceutical Evotec Rui Wang
BRIEF published on 05/12/2026 at 22:30, 4 months 3 days ago Evotec SE Raises €116.1 Million through Convertible Bonds Frankfurt Stock Exchange Convertible Bonds Evotec SE Long-term Growth Project Horizon
PRESS RELEASE published on 05/12/2026 at 22:25, 4 months 3 days ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds Evotec SE successfully placed €116.1 million convertible bonds with a maturity of seven years at a 2.625% interest rate, aiming to strengthen the Company's operating model Investor Relations Convertible Bonds Financial News Evotec SE Corporate Action
Published on 09/16/2026 at 16:55, 4 hours 42 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 6 hours 37 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 7 hours 37 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 13:30, 8 hours 7 minutes ago Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Published on 09/16/2026 at 21:15, 22 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 1 hour 9 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 19:05, 2 hours 32 minutes ago EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026
Published on 09/16/2026 at 18:22, 3 hours 15 minutes ago EQS-Adhoc: elumeo SE resolves on a capital increase against cash contributions, ex-cluding pre-emptive rights, and a move to the Scale segment
Published on 09/16/2026 at 18:11, 3 hours 25 minutes ago EQS-Adhoc: Berentzen-Gruppe Aktiengesellschaft confirms rumours regarding negotiations on a voluntary takeover offer by SAZERAC COMPANY, INC.
Published on 09/16/2026 at 17:45, 3 hours 52 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 14 hours 37 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 3 hours ago Report on the Combined General Meeting of the 10th of September 2026